Profile Details

Create Project

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Hire Dr. Sanchari S.

India

Freelance Science Writer

Profile Summary

I did my PhD in physiology. After obtaining PhD, I gained intense knowledge in cancer biology during my 6 years of postdoctoral tenure. Throughout my academic career, I wrote more than 10 scientific articles, helped my supervisor to write several grant applications, and also peer reviewed several scientific articles for leading journals.

Subject Matter Expertise

• ☆ Biology/Life Sciences
• ☆ Biochemistry
• ☆ Oxidative Stress & Mitochondrial Function
• ☆ Molecular Biology
• ☆ Biomarkers
• ☆ Cell Aging
• ☆ Oncology
• ☆ Peer Review
• ☆ Technical & Scientific Writing
• ☆ Grant Writing

Services

• Writing
• Consulting
• Product Development

Work Experience

Scientific writer

JoVE (Journal of Visualized Experiments)

October 2017 - Present

Scientific writer

Cognibrain

May 2017 - Present

Freelance publication support

Cactus Communications Private Limited

October 2016 - Present

Postdoctoral Fellow

Weizmann Institute of Science

November 2012 - September 2016

Research Associate

National Brain Research Centre

May 2010 - October 2012

Education

PhD

Defence Institute of Physiology and Allied Science

December 2004 - April 2010

PhD

DRDO Defence Institute of Physiology and Allied Sciences

December 2004 - April 2010

Certifications

• Certification details not provided.

Publications

JOURNAL ARTICLE

Antioxidant and redox status after maximal aerobic exercise at high altitude in acclimatized lowlanders and native highlanders. European Journal of applied Physiology.

Protein nitration, lipid peroxidation and DNA damage at high altitude in acclimatized lowlanders and native highlanders: relation with oxygen consumption. Respiratory Physiology and Neurobiology.

IGF-1 induced HIF-1α-TLR9 cross talk regulates inflammatory responses in glioma. Cellular Signalling.

ATM-NF κB Axis-Driven TIGAR Regulates Sensitivity of Glioma Cells to Radiomimetics in the Presence of TNF α. Call death and disease.

An antibody to amphiregulin, an abundant growth factor in patients’ fluids, inhibits ovarian tumors. Oncogene.